A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma
Clinical trial NCT06653322 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06653322
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2027-09-01
- Enrollment
- 401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.